CN106434592A - Method for rapid purification of Stoffel fragment Taq enzyme - Google Patents
Method for rapid purification of Stoffel fragment Taq enzyme Download PDFInfo
- Publication number
- CN106434592A CN106434592A CN201610180456.XA CN201610180456A CN106434592A CN 106434592 A CN106434592 A CN 106434592A CN 201610180456 A CN201610180456 A CN 201610180456A CN 106434592 A CN106434592 A CN 106434592A
- Authority
- CN
- China
- Prior art keywords
- taq enzyme
- taq
- stoffel fragment
- fast purifying
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 60
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 60
- 239000012634 fragment Substances 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000000746 purification Methods 0.000 title abstract description 14
- 238000009835 boiling Methods 0.000 claims abstract description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000894006 Bacteria Species 0.000 claims abstract description 10
- 239000012536 storage buffer Substances 0.000 claims abstract description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000008346 aqueous phase Substances 0.000 claims abstract description 4
- 239000012074 organic phase Substances 0.000 claims abstract description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 3
- 239000006228 supernatant Substances 0.000 claims description 10
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 230000009089 cytolysis Effects 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 2
- 238000005336 cracking Methods 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims 3
- 230000004087 circulation Effects 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 238000003672 processing method Methods 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 abstract description 8
- 238000012408 PCR amplification Methods 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 5
- 238000012258 culturing Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- 238000011109 contamination Methods 0.000 description 12
- 102000039446 nucleic acids Human genes 0.000 description 11
- 108020004707 nucleic acids Proteins 0.000 description 11
- 150000007523 nucleic acids Chemical class 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108010006785 Taq Polymerase Proteins 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000003321 amplification Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 101150067314 aadA gene Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- BUNGCZLFHHXKBX-UHFFFAOYSA-N 8-methoxypsoralen Natural products C1=CC(=O)OC2=C1C=C1CCOC1=C2OC BUNGCZLFHHXKBX-UHFFFAOYSA-N 0.000 description 1
- 101150069979 BADH gene Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- 238000003302 UV-light treatment Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960004469 methoxsalen Drugs 0.000 description 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种快速纯化Stoffel片段Taq酶的方法,通过在LB培养基中过夜培养,取菌液接种于LB培养基中继续培养至OD600为0.4,利用4×Taq storage buffer重悬菌体,菌体被置于沸水浴中,煮沸裂解后离心,用水相/有机磷酸系统处理,在含有Taq酶的上层有机相中加入等体积无菌甘油,贮于‑20℃,备用。本发明方法具有更可靠、更快和简单的特点,可为PCR扩增技术的广泛应用提供新的纯化技术。The invention discloses a method for quickly purifying Stoffel fragment Taq enzyme. After culturing overnight in LB medium, the bacterial solution is inoculated in LB medium to continue culturing until OD 600 is 0.4, and the bacteria are resuspended in 4×Taq storage buffer Bacterial cells were placed in a boiling water bath, boiled and lysed, centrifuged, treated with an aqueous phase/organic phosphoric acid system, an equal volume of sterile glycerol was added to the upper organic phase containing Taq enzyme, and stored at -20°C for later use. The method of the invention has the characteristics of being more reliable, faster and simpler, and can provide a new purification technology for the wide application of PCR amplification technology.
Description
技术领域technical field
本发明属于分子生物学技术领域,具体涉及一种快速纯化Stoffel片段Taq酶的方法。The invention belongs to the technical field of molecular biology, in particular to a method for rapidly purifying Stoffel fragment Taq enzyme.
背景技术Background technique
聚合酶链式反应(PCR)是分子生物学研究中使用最广泛的DNA聚合酶,在PCR过程中,需要来源于高温下稳定的Thermus aquaticus的DNA聚合酶。基因工程菌株的发展,大大提高了Taq酶的产量。Lawyer等首次报道了全长Taq聚合酶的基因序列,其编码832个氨基酸,产生94KDa的Taq酶。随后,它们对Taq的N端进行了截短改良,使之表达544个氨基酸,61KDa的蛋白。与全长Taq聚合酶相比,缺失5’-3’内切酶活性,可以在PCR扩增中,提高保真度;此外,Stoffel片段Taq酶具有更高的耐热特性,97.5℃下半衰期为21分钟,而全长Taq仅为9分钟。这两个特性使Stoffel片段Taq酶在生物技术应用中使用更广泛。Polymerase chain reaction (PCR) is the most widely used DNA polymerase in molecular biology research. During the PCR process, DNA polymerase derived from Thermus aquaticus, which is stable at high temperature, is required. The development of genetic engineering strains has greatly improved the production of Taq enzyme. Lawyer et al. first reported the gene sequence of the full-length Taq polymerase, which encodes 832 amino acids and produces a 94KDa Taq enzyme. Subsequently, they truncated and improved the N-terminus of Taq to express a protein of 544 amino acids and 61KDa. Compared with the full-length Taq polymerase, the lack of 5'-3' endonuclease activity can improve the fidelity in PCR amplification; in addition, the Stoffel fragment Taq enzyme has higher heat resistance characteristics, and the half-life at 97.5°C is 21 minutes, while the full-length Taq is only 9 minutes. These two properties make Stoffel fragment Taq enzymes more widely used in biotechnology applications.
由于Stoffel片段Taq聚合酶的广泛应用,有必要发展出一种简单、高效的纯化方式来大量获取Stoffel片段Taq酶,以满足实验室对Taq酶的需求。利用Stoffel片段的耐热特性,本申请发展了一种简单、便利的纯化方法,使用这一方法,整个纯化过程仅需1~2小时,1L菌液可以得到80mg,约1.6×107个单位的Taq酶。与现有纯化技术相比,该方法不仅简单,而且省时。Due to the wide application of Stoffel fragment Taq polymerase, it is necessary to develop a simple and efficient purification method to obtain a large amount of Stoffel fragment Taq polymerase to meet the needs of laboratories for Taq enzymes. Utilizing the heat-resistant properties of Stoffel fragments, the applicant has developed a simple and convenient purification method. Using this method, the entire purification process only takes 1 to 2 hours, and 80 mg, about 1.6×10 7 units, can be obtained from 1 L of bacterial liquid Taq enzyme. Compared with existing purification techniques, the method is not only simple, but also time-saving.
发明内容Contents of the invention
本发明的目的在于提供一种简单、快速、实用的提取纯化TaqDNA聚合酶的方法。The purpose of the present invention is to provide a simple, fast and practical method for extracting and purifying TaqDNA polymerase.
本发明具体通过以下技术方案实现:The present invention is specifically realized through the following technical solutions:
一种快速纯化Stoffel片段Taq酶的方法,具体包括以下步骤:A method for rapidly purifying Stoffel fragment Taq enzyme, specifically comprising the following steps:
1)工程菌的活化和表达:取Stoffel片段Taq DNA聚合酶工程菌接种在LB培养基中,于37℃培养过夜;1) Activation and expression of engineered bacteria: Inoculate engineered bacteria with Stoffel fragment Taq DNA polymerase in LB medium and culture overnight at 37°C;
2)按照比例,取菌液接种于LB培养基中,于37℃继续培养至OD600为0.4,加入IPTG至终浓度为0.5mM,继续培养12-16小时;2) According to the proportion, take the bacterial liquid and inoculate it in LB medium, continue to cultivate at 37°C until the OD 600 is 0.4, add IPTG to a final concentration of 0.5mM, and continue to cultivate for 12-16 hours;
3)于4000g离心5min,收集菌体,用4×Taq storage buffer重悬菌体,菌体被置于沸水浴中,煮沸裂解;3) Centrifuge at 4000g for 5 minutes to collect the cells, resuspend the cells with 4×Taq storage buffer, place the cells in a boiling water bath, and boil to lyse;
4)裂解后在4℃下16000g离心10min除去细胞残体和变性后的蛋白,上清液采用水相/有机磷酸系统处理后备用。4) After lysis, centrifuge at 16,000 g for 10 min at 4°C to remove cell residues and denatured proteins, and the supernatant is treated with an aqueous phase/organic phosphoric acid system for later use.
本发明所述的LB培养基中含有100μg/ml的Kan。The LB medium of the present invention contains 100 μg/ml Kan.
本发明所述的菌液与LB培养基按照体积比1:100接种。The bacterial solution of the present invention is inoculated with the LB medium according to the volume ratio of 1:100.
本发明所述的Taq storage buffer具体为:20mM Tris-HCl pH 8.0,10mM DTT,0.1mM EDTA,100mM KCl,0.5%Nonidet P40,0.5%Tween 20。The Taq storage buffer of the present invention is specifically: 20mM Tris-HCl pH 8.0, 10mM DTT, 0.1mM EDTA, 100mM KCl, 0.5% Nonidet P40, 0.5% Tween 20.
本发明所述的沸水浴加热条件为:每4min一个循环,共两个循环,加热8min。The boiling water bath heating condition of the present invention is: every 4min one cycle, totally two cycles, heating 8min.
本发明步骤(4)所述的上清液处理方法具体为:加入10%无菌平衡磷酸二氢钾混匀,加等体积的无水乙醇混匀,2000g离心2min,在含有Taq酶的上层有机相中加入等体积无菌甘油,贮于-20℃。The supernatant treatment method described in the step (4) of the present invention is specifically: add 10% sterile balanced potassium dihydrogen phosphate and mix, add an equal volume of dehydrated alcohol and mix, 2000g centrifugal 2min, in the upper layer containing Taq enzyme An equal volume of sterile glycerol was added to the organic phase and stored at -20°C.
本发明的有益效果为:1)快速:在单一的贮存缓冲液,仅需1-2个小时就可完成整个纯化过程,且不需特殊设备和不使用有毒试剂;2)可靠稳定:经稀释10倍后的Taq酶于-20℃贮藏12个月后,其活性没有发生改变;经37℃到72℃的过夜保温测试,也没有发现核酸酶的活性;3)采用aqueous/organic系统来简便和高效的去除核酸污染,不会降低Taq酶的产量。The beneficial effects of the present invention are: 1) fast: in a single storage buffer, the whole purification process can be completed in only 1-2 hours, and no special equipment and no toxic reagents are used; 2) reliable and stable: after dilution After 10 times the Taq enzyme was stored at -20°C for 12 months, its activity did not change; after an overnight incubation test from 37°C to 72°C, no nuclease activity was found; 3) The aqueous/organic system is used for convenience And efficiently remove nucleic acid contamination without reducing the yield of Taq enzyme.
附图说明Description of drawings
图1是采用所纯化的Taq酶进行不同浓度稀释后对aadA基因进行PCR扩增的结果;Fig. 1 is the result of carrying out PCR amplification to aadA gene after using purified Taq enzyme to dilute at different concentrations;
图2是商业化Taq酶同本技术纯化的Taq酶采用不同片段大小的基因进行扩增的结果;Figure 2 is the result of amplifying the commercialized Taq enzyme and the Taq enzyme purified by this technology using genes of different fragment sizes;
图3是所纯化的Stoffel片段的SDS-PAGE电泳结果;Fig. 3 is the SDS-PAGE electrophoresis result of the purified Stoffel fragment;
图4是不同处理时间所纯化的Stoffel片段SDS-PAGE电泳结果;Fig. 4 is the SDS-PAGE electrophoresis result of the Stoffel fragment purified by different treatment time;
图5是Aqueous/Organic biphasic系统处理前后煮沸上清液中核酸污染情况。Figure 5 shows the nucleic acid contamination in the boiled supernatant before and after treatment with the Aqueous/Organic biphasic system.
具体实施方式detailed description
下面结合实施例对本发明做进一步的说明,以下所述,仅是对本发明的较佳实施例而已,并非对本发明做其他形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更为同等变化的等效实施例。凡是未脱离本发明方案内容,依据本发明的技术实质对以下实施例所做的任何简单修改或等同变化,均落在本发明的保护范围内。The present invention will be further described below in conjunction with the embodiments. The following descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention to other forms. Changes to equivalent embodiments with equivalent changes. Any simple modifications or equivalent changes made to the following embodiments according to the technical essence of the present invention without departing from the solution content of the present invention fall within the protection scope of the present invention.
实施例1Example 1
1)材料和方法1) Materials and methods
菌株与质粒Strains and plasmids
pBio-Taq表达载体由丁雄飞博士友好赠送,其基本载体为pET-29a。其中,含有T7启动子和Taq基因序列。与Lawyer等报道相一致,该基因表达61KDa的Stoffel片段。BL21(DE3)作为载体寄主,细菌带有pLysS质粒使其更易于破碎释放出重组蛋白。The pBio-Taq expression vector was kindly donated by Dr. Xiongfei Ding, and its basic vector is pET-29a. Wherein, it contains T7 promoter and Taq gene sequence. Consistent with Lawyer et al.'s report, the gene expresses a 61KDa Stoffel fragment. BL21(DE3) is used as the vector host, and the bacteria carry the pLysS plasmid to make it easier to break and release the recombinant protein.
2)截短的Taq聚合酶Stoffel片段的纯化2) Purification of the truncated Taq polymerase Stoffel fragment
转化BL21细菌的质粒被接种在5ml含kan(100μg/ml)的LB培养基中,于37℃培养过夜。按照1:100比例,取1ml菌液接种于100ml含Amp(100μg/ml)的LB培养基中,于37℃继续培养至OD600为0.4,加入IPTG至终浓度为0.5mM,继续培养12-16小时。于4000g离心5min,收集菌体,用5ml 4×Taq storage buffer(20mM Tris-HCl(pH 8.0),10mM DTT,0.1mM EDTA,100mM KCl,0.5%Nonidet P40,0.5%Tween 20)重悬菌体,菌体被放入沸水浴不同时间(0-12min)和次数(4min per cycle)。煮沸裂解后,4℃下16,000g离心10min除去细胞残体和变性后的蛋白,然后转上清入新管。为了除去污染的核酸,上清液采用水相/有机磷酸系统,含有Taq酶的上层有机相转入新管,加入等体积无菌甘油,贮于-20℃,使用前进行适当稀释。The plasmid for transforming BL21 bacteria was inoculated in 5 ml of LB medium containing kan (100 μg/ml), and cultured at 37° C. overnight. According to the ratio of 1:100, take 1ml of the bacterial liquid and inoculate it into 100ml of LB medium containing Amp (100μg/ml), continue to cultivate at 37°C until the OD600 is 0.4, add IPTG to the final concentration of 0.5mM, and continue to cultivate for 12-16 Hour. Centrifuge at 4000g for 5min, collect the cells, and resuspend the cells in 5ml 4×Taq storage buffer (20mM Tris-HCl(pH 8.0), 10mM DTT, 0.1mM EDTA, 100mM KCl, 0.5%Nonidet P40, 0.5%Tween 20) , the bacteria were put into the boiling water bath for different time (0-12min) and times (4min per cycle). After boiling and lysis, centrifuge at 16,000g for 10 minutes at 4°C to remove cell residues and denatured proteins, then transfer the supernatant to a new tube. In order to remove contaminating nucleic acids, the supernatant was used in the aqueous phase/organic phosphate system, and the upper organic phase containing Taq enzyme was transferred to a new tube, and an equal volume of sterile glycerol was added, stored at -20°C, and properly diluted before use.
实施例2蛋白分析和活性测定Example 2 Protein analysis and activity determination
1)实验方法1) Experimental method
采用Bradford法测定Taq蛋白的浓度。取10μl实施例1纯化所得样品进行SDS-PAGE电泳估计蛋白成分。The concentration of Taq protein was determined by Bradford method. Take 10 μl of the sample purified in Example 1 and perform SDS-PAGE electrophoresis to estimate the protein composition.
将所纯化的截短Taq聚合酶稀释后,进行PCR扩增,以测定其酶活性,采用Takara公司Taq酶作为对照。纯化的截短Taq聚合酶用1×Taq storage buffer按1:5,1:10,1:20,1:50进行稀释,扩增PU C18的克隆片段。50μl体系中,采用0.2(l的Taq酶,反应体系为1×PCRreaction buffer(10mM KCl,20mM Tris-HCl(pH 8.8),10mM(NH4)2SO4,0.1%TritonX-100,0.1mg/ml BSA),0.2mM d NTPs,2.0mM MgSO4,0.2(M引物(5’-atggcaccacaaacagagg-3’和5’-ttatttgccgactaccttgg-3’)扩增800bp的aadA基因(编码aminoglycoside 3’-adenylytransferase),25ng模板DNA。After the purified truncated Taq polymerase was diluted, PCR amplification was performed to measure its enzyme activity, and Taq enzyme from Takara Company was used as a control. The purified truncated Taq polymerase was diluted with 1×Taq storage buffer at 1:5, 1:10, 1:20, 1:50 to amplify the cloned fragment of PU C18. In the 50μl system, use 0.2(l Taq enzyme, the reaction system is 1×PCR reaction buffer (10mM KCl, 20mM Tris-HCl (pH 8.8), 10mM (NH4)2SO4, 0.1% TritonX-100, 0.1mg/ml BSA) , 0.2mM d NTPs, 2.0mM MgSO4, 0.2(M primers (5'-atggcaccacaaacagagg-3' and 5'-ttatttgccgactaccttgg-3') amplified 800bp aadA gene (encoding aminoglycoside 3'-adenylytransferase), 25ng template DNA.
反应条件为:95℃总变性3min,94℃变性60s,55℃退火60s,72℃延伸180s,共进行30个循环,PCR反应在MJ research Minicycler(美国)反应仪上进行。PCR程序完成后,分别取1μl,2μl,5μl,10μl PCR产物在1.2%的琼脂糖凝胶上进行电泳分析,缓冲液为TBE,分子量标准采用DL2000。为了测试Taq酶对不同大小片段的扩增能力,分别扩增了500bp的IGF-1基因,1500bpBADH基因和2.7kb的烟草叶绿体trnI-trnA基因片段,以验证Taq酶的扩增效率。The reaction conditions were: total denaturation at 95°C for 3 minutes, denaturation at 94°C for 60 s, annealing at 55°C for 60 s, and extension at 72°C for 180 s, for a total of 30 cycles. The PCR reaction was performed on a MJ research Minicycler (USA) reactor. After the completion of the PCR program, 1 μl, 2 μl, 5 μl, and 10 μl of the PCR products were taken for electrophoresis analysis on 1.2% agarose gel, the buffer was TBE, and the molecular weight standard was DL2000. In order to test the amplification ability of Taq enzyme to fragments of different sizes, the 500bp IGF-1 gene, the 1500bp BADH gene and the 2.7kb tobacco chloroplast trnI-trnA gene fragment were respectively amplified to verify the amplification efficiency of Taq enzyme.
2)结果2) Results
采用商业化的Taq酶作为对照,进行梯度稀释,对所纯化的Taq 酶Stoffel片段通过PCR扩增,进行了活性测定(图1)。Using commercial Taq enzyme as a control, serial dilution was performed, and the activity of the purified Stoffel fragment of Taq enzyme was amplified by PCR, and the activity was determined ( FIG. 1 ).
使用稀释10倍的Taq酶所扩增的0.8kb的片段,取1μl PCR产物进行电泳,其产量与商业化的Taq酶2μl PCR产物相当(泳道2),因此,使用稀释10倍的Taq酶其活性是商业化的Taq酶活性的2倍。所以,稀释10倍的Taq酶活性为10units/μl,母液浓度为100units/μl。根据这个结果,可以得出,1L的菌液可以得到1.6×107units的Taq酶。此外,当Taq酶稀释至20或50倍后,仅有很少的酶活力发现。For the 0.8kb fragment amplified by 10-fold diluted Taq enzyme, take 1 μl of PCR product for electrophoresis, and its yield is equivalent to 2 μl PCR product of commercial Taq enzyme (lane 2). Therefore, use 10-fold diluted Taq enzyme for its The activity is twice that of the commercial Taq enzyme. Therefore, the activity of Taq diluted 10 times is 10 units/μl, and the concentration of the mother solution is 100 units/μl. According to this result, it can be concluded that 1.6×10 7 units of Taq enzyme can be obtained from 1 L of bacterial solution. In addition, when the Taq enzyme was diluted to 20 or 50 times, only little enzyme activity was found.
为了验证Taq酶的稳定性,采用不同片段大小的DNA片段进行扩增,结果如图2。稀释10倍后的Taq酶与商业化的Taq酶(Takara)分别扩增0.5kb至3.0kb的DNA片段。结果表明,所纯化的Taq酶与商业化的Taq酶扩增结果一致。In order to verify the stability of the Taq enzyme, DNA fragments of different fragment sizes were used for amplification, and the results are shown in Figure 2. The 10-fold diluted Taq enzyme and commercial Taq enzyme (Takara) amplified DNA fragments from 0.5 kb to 3.0 kb, respectively. The results showed that the purified Taq enzyme was consistent with the amplification result of commercial Taq enzyme.
实施例3纯化方法的建立The establishment of embodiment 3 purification method
1)煮沸裂解时间的确定1) Determination of boiling cracking time
为了比较不同煮沸裂解时间对Taq酶Sottfel片段纯化的影响,采用0,2,4,6,8,10和12min等7个煮沸时间来进行分析,结果如图3所示。In order to compare the effects of different boiling and cleavage times on the purification of Taq enzyme Sottfel fragments, 7 boiling times of 0, 2, 4, 6, 8, 10 and 12 min were used for analysis, and the results are shown in Figure 3.
从图3中,预期的Stoffel fragment(61kDa)被释放到4-fold Taq storagebuffer,煮沸8分钟具有较高的Taq酶产量,且没有杂蛋白污染。未煮沸对照没有Taq蛋白发现。在未采用IPTG诱导的对照中,仅有微量的Taq酶产生。From Figure 3, the expected Stoffel fragment (61kDa) was released into 4-fold Taq storagebuffer, boiled for 8 minutes with higher Taq enzyme yield, and no foreign protein contamination. No Taq protein was found in the unboiled control. In the control not induced by IPTG, only a small amount of Taq enzyme was produced.
2)煮沸次数2) Boiling times
本实验中,采用煮沸4分钟后,4℃,16,000g离心10min,来作为一个循环。结果如图4,经2个循环,共煮沸8分钟后,Taq酶被高量产生。同时,发现经三次循环,Taq酶产量有所降低。同时,从图中可以看出,很少有其它的杂蛋白污染。In this experiment, after boiling for 4 minutes, centrifugation at 16,000g for 10 minutes at 4°C was used as a cycle. The results are shown in Figure 4. After 2 cycles and co-boiling for 8 minutes, Taq enzyme was produced in a high amount. At the same time, it was found that the production of Taq enzyme decreased after three cycles. At the same time, it can be seen from the figure that there is very little other foreign protein contamination.
3)通过Aqueous/Organic biphasic系统除去核酸污染3) Remove nucleic acid contamination by Aqueous/Organic biphasic system
为了验证核酸污染,取10μl煮沸上清液进行琼脂糖凝胶电泳分析,结果如图5。In order to verify nucleic acid contamination, 10 μl of boiled supernatant was taken for agarose gel electrophoresis analysis, the results are shown in Figure 5.
结果显示,未经biophasic处理的样品存在有核酸污染(泳道1-3)。为了消除核酸污染,采用2个简单步骤来进行:1)加入10%无菌平衡磷酸二氢钾(pH10.3),混匀几秒;2)加等体积的无水乙醇进入上步骤1中的溶液中,混匀几秒。2,000g离心2min,包含有Taq酶的上清液转入新管,加入等体积无菌甘油后,贮于-20℃。通过以上步骤,可以有效的去除核酸污染(泳道4)。The results showed that the samples without biophasic treatment had nucleic acid contamination (lanes 1-3). In order to eliminate nucleic acid contamination, use 2 simple steps: 1) Add 10% sterile balanced potassium dihydrogen phosphate (pH10.3), mix for a few seconds; 2) Add an equal volume of absolute ethanol into the above step 1 solution, mix for a few seconds. Centrifuge at 2,000 g for 2 min, transfer the supernatant containing Taq enzyme into a new tube, add an equal volume of sterile glycerol, and store at -20°C. Through the above steps, nucleic acid contamination can be effectively removed (lane 4).
综上所述,与前人的报道相比,本方法有以下几个优势:在单一的贮存缓冲液,仅需1-2个小时就可完成整个纯化过程,且不需特殊设备和不使用有毒试剂。1L菌液可以得到80mg,约1.6×107个单位的Taq酶,结果与Desai和Lawyer’s等报道的相一致。经稀释10倍后的Taq酶于-20℃贮藏12个月后,其活性没有发生改变。经37℃到72℃的过夜保温测试,也没有发现核酸酶的活性。In summary, compared with previous reports, this method has the following advantages: In a single storage buffer, the entire purification process can be completed in only 1-2 hours, and no special equipment and no Toxic reagent. 80mg, about 1.6×107 units of Taq enzyme can be obtained from 1L of bacterial solution, and the results are consistent with those reported by Desai and Lawyer’s et al. After 10-fold diluted Taq enzyme was stored at -20°C for 12 months, its activity did not change. No nuclease activity was found in the overnight incubation test at 37°C to 72°C.
在对纯化条件的优化过程中,还考虑到了Taq酶的产量,实验表明,煮沸时间和次数对酶的产量有一定的影响。2次循环,煮沸8分钟是最适的,在这样的条件下,大量的大肠杆菌蛋白被变性去除,同时,Taq酶释放进上清液中。煮沸时间超过8分钟,Taq酶产量有所降低。此外,离心率也对蛋白的纯化有一定影响,推荐采用4℃下16,000g离心10min来去除蛋白。In the process of optimizing the purification conditions, the yield of Taq enzyme was also taken into consideration. Experiments showed that the boiling time and times had a certain influence on the yield of the enzyme. 2 cycles, boiling for 8 minutes is the most suitable. Under such conditions, a large amount of E. coli proteins are denatured and removed, and at the same time, Taq enzyme is released into the supernatant. The production of Taq enzyme decreased when the boiling time was more than 8 minutes. In addition, the centrifugation rate also has a certain impact on protein purification. It is recommended to use centrifugation at 16,000g for 10 minutes at 4°C to remove protein.
在Taq酶纯化过程中,如果采用进行RAPD等分析,有必要去除核酸的污染。在前人的研究中,几种方法被用来去除核酸污染,例如PEI制备和离子交换层析、8-methoxypsoralen处理、UV光照处理、限制内切酶消化和透析。这些方法不仅费时,且有可能降低Taq酶的产量。本文中采用了aqueous/organic系统来简便和高效的去除核酸污染。During the purification process of Taq enzyme, if RAPD and other analyzes are used, it is necessary to remove nucleic acid contamination. In previous studies, several methods were used to remove nucleic acid contamination, such as PEI preparation and ion-exchange chromatography, 8-methoxypsoralen treatment, UV light treatment, restriction endonuclease digestion, and dialysis. These methods are not only time-consuming, but also may reduce the yield of Taq enzyme. In this paper, an aqueous/organic system is used to remove nucleic acid contamination easily and efficiently.
总之,本申请提供了一种更可靠、更快和简单的纯化Taq酶的方法。使用煮沸法,可以在1-2小时完成大量高活性的Taq酶的纯化,该方法可为PCR扩增技术的广泛应用提供新的纯化技术。In summary, the present application provides a more reliable, faster and simpler method for purifying Taq enzyme. Using the boiling method, a large amount of highly active Taq enzyme can be purified within 1-2 hours, and this method can provide a new purification technology for the wide application of PCR amplification technology.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610180456.XA CN106434592A (en) | 2016-03-28 | 2016-03-28 | Method for rapid purification of Stoffel fragment Taq enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610180456.XA CN106434592A (en) | 2016-03-28 | 2016-03-28 | Method for rapid purification of Stoffel fragment Taq enzyme |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106434592A true CN106434592A (en) | 2017-02-22 |
Family
ID=58183428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610180456.XA Pending CN106434592A (en) | 2016-03-28 | 2016-03-28 | Method for rapid purification of Stoffel fragment Taq enzyme |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106434592A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090209005A1 (en) * | 2004-07-26 | 2009-08-20 | Konstantin Ignatov | Chimeric dna polymerase |
CN103045554A (en) * | 2012-11-29 | 2013-04-17 | 成都福际生物技术有限公司 | Method for preparing hot start Taq polymerase |
CN103966183A (en) * | 2014-04-30 | 2014-08-06 | 厦门安普利生物工程有限公司 | Method for extracting purified Taq DNA polymerases |
CN104312992A (en) * | 2014-10-24 | 2015-01-28 | 福建农林大学 | Method for simply and quickly extracting and purifying Taq-DNA polymerase |
-
2016
- 2016-03-28 CN CN201610180456.XA patent/CN106434592A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090209005A1 (en) * | 2004-07-26 | 2009-08-20 | Konstantin Ignatov | Chimeric dna polymerase |
CN103045554A (en) * | 2012-11-29 | 2013-04-17 | 成都福际生物技术有限公司 | Method for preparing hot start Taq polymerase |
CN103966183A (en) * | 2014-04-30 | 2014-08-06 | 厦门安普利生物工程有限公司 | Method for extracting purified Taq DNA polymerases |
CN104312992A (en) * | 2014-10-24 | 2015-01-28 | 福建农林大学 | Method for simply and quickly extracting and purifying Taq-DNA polymerase |
Non-Patent Citations (2)
Title |
---|
ZHENGAN YANG ET AL.: "Rapid purification of truncated Taq DNA polymerase Stoffel fragment by boiling lysis of bacterial expression cultures", 《BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY》 * |
刘天磊 等: "大肠杆菌表达的Taq DNA聚合酶的纯化", 《遗传》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6864024B2 (en) | Digital biological converter | |
CN110325641B (en) | Cell-free expression system for energy regeneration based on inorganic polyphosphates | |
Savalia et al. | Genomic and proteomic analysis of phiEco32, a novel Escherichia coli bacteriophage | |
KR20240055073A (en) | Class II, type V CRISPR systems | |
CN102816786B (en) | Simple and efficient method for preparing and purifying TaqDNA polymerase | |
CN114423870A (en) | Cell-free production of ribonucleic acids | |
WO2020243026A1 (en) | Methods and compositions for manufacturing polynucleotides | |
CN116179507B (en) | A T7 RNA polymerase mutant and its preparation method and application | |
CN106399299A (en) | Method for improving activity of large-fragment Geobacillus stearothermophilus (Bst) DNA polymerase through point mutation and application | |
CN110499305A (en) | Expression vector, construction method and expression purification of nuclease protein Cas9 | |
Marsin et al. | A rolling circle replication initiator protein with a nucleotidyl‐transferase activity encoded by the plasmid pGT5 from the hyperthermophilic archaeon Pyrococcus abyssi | |
CN104312992B (en) | Method for simply and quickly extracting and purifying Taq-DNA polymerase | |
KR20240049306A (en) | Enzymes with RUVC domains | |
CN104593400A (en) | Method for improving expression level of trehalose synthase gene by molecular chaperone co-expression | |
Atsumi et al. | A new method to isolate total dsRNA | |
Zhao et al. | Characterization of an endonuclease in rice stripe tenuivirus Pc1 in vitro | |
US10329545B2 (en) | Polymerases | |
CN112029744A (en) | DNA polymerase and its encoding gene, preparation method and PCR application | |
CN106434592A (en) | Method for rapid purification of Stoffel fragment Taq enzyme | |
CN104805097A (en) | Coding sequences and applications of isatis indigotica fortune pinoresinol reductase protein | |
Fernández-López et al. | Functional properties and structural requirements of the plasmid pMV158-encoded MobM relaxase domain | |
Yang et al. | Rapid purification of truncated Taq DNA polymerase Stoffel fragment by boiling lysis of bacterial expression cultures | |
CN102899316B (en) | Enzymatic synthesis method for DNA phosphorothioation | |
CN105861533A (en) | Recombinant vector for inducing Escherichia coli cracking through magnesium ions, and application thereof | |
CN105255922B (en) | A kind of alginate lyase SHA-5 genes and its prokaryotic expression carrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |
|
RJ01 | Rejection of invention patent application after publication |